Prince Henry’s Institute

Home > About Us > Publications

 

Publications

 

 

 

2011

Aitken RJ, Findlay JK, Hutt KJ, Kerr JB. Apoptosis in the germ line. Reproduction 2011;141: 139-150.

Alexiadis M, Eriksson N, Jamieson S, Davis M, Drummond AE, Chu S, Clyne CD, Muscat GE, Fuller PJ. Nuclear receptor profiling of ovarian granulosa cell tumors. Hormones & Cancer 2011;2: 157-169.

Aljofan M, Singh H, Ho H, Xie S, Zhu Y, Sun Z, Guo X, Wang J, Nie G. Inhibition of proprotein convertase 5/6 activity: potential for nonhormonal women-centered contraception. Contraception 2011 Nov 11 [Epub ahead of print]

Al-Khan A, Aye IL, Barsoum I, Borbelyd A, Cebral E, Cerchi G, Clifton VL, Collins S, Cotechini T, Davey A, Flores-Martin J, Fournier T, Franchi AM, Fretes RE, Graham CH, Godbole G, Hansson SR, Headley PL, Ibarra C, Jawerbaum A, Kemmerling U, Kudo Y, Lala PK, Lassance L, Lewis RM, Menkhorst E, Morris C, Nobuzane T, Ramos G, Rote N, Saffery R, Salafia C, Sarr D, Schneider H, Sibley C, Singh AT, Sivasubramaniyam TS, Soares MJ, Vaughan O, Zamudio S, Lash GE. IFPA Meeting 2010 Workshops Report II: Placental pathology; Trophoblast invasion; Fetal sex; Parasites and the placenta; Decidua and embryonic or fetal loss; Trophoblast differentiation and syncytialisation. Placenta 2011;32: S90-S99.

Allan CA, Peverill RE, Strauss BJ, Forbes EA, McLachlan RI. Waist-to-height ratio as a predictor of serum testosterone in ageing men with symptoms of androgen deficiency. Asian Journal of Andrology 2011;13: 424-431.

Allan CA, Strauss BJ, Forbes EA, Paul E, McLachlan RI. Variability in total testosterone levels in ageing men with symptoms of androgen deficiency. International Journal of Andrology 2011;34: 212-216.

Bagheri-Fam S, Argentaro A, Svingen T, Combes AN, Sinclair AH, Koopman P, Harley VR. Defective survival of proliferating Sertoli cells and androgen receptor function in a mouse model of the ATR-X syndrome. Human Molecular Genetics 2011;20: 2213-2224.

Bernard P, Ryan J, Sim H, Czech DP, Sinclair AH, Koopman P, Harley VR. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer. Endocrinology 2011 Nov 29 [Epub ahead of print]

Biadasiewicz K, Sonderegger S, Haslinger P, Haider S, Saleh L, Fiala C, Pollheimer J, Knofler M. Transcription factor AP-2 alpha promotes EGF-dependent invasion of human trophoblast. Endocrinology 2011;152: 1458-1469.

Bilandzic M, Stenvers KL. Betaglycan: A multifunctional accessory. Molecular and Cellular Endocrinology 2011;339: 180-189.

Boon WC, Horne MK. Aromatase and its inhibition in behaviour, obsessive compulsive disorder and Parkinsonism. Steroids 2011;76: 816-819.

Brown KA, McInnes KJ, Takagi K, Ono K, Hunger NI, Wang L, Sasano H, Simpson ER. LKB1 expression is inhibited by estradiol-17beta in MCF-7 cells. The Journal of Steroid Biochemistry and Molecular Biology 2011;127: 439-443.

Burger H, Teede H. Endocrinology of the menopause and hormone replacement therapy. In: Wass JAH, Stewart PN, editors. Oxford Textbook of Endocrinology and Diabetes. 2nd ed: Oxford University Press; 2011, p. 1492-1503.

Cato AC, Fuller PJ. What is in a name? Molecular and Cellular Endocrinology 2011 Aug 18 [Epub ahead of print]

Chand A, Legge M. Stereological assessment of developing mouse ovarian follicles in an in vitro culture system. Anatomical Record 2011;294: 379-383.

Chand AL, Herridge KA, Howard TL, Simpson ER, Clyne CD. Tissue-specific regulation of aromatase promoter II by the orphan nuclear receptor LRH-1 in breast adipose stromal fibroblasts. Steroids 2011;76: 741-744.

Chand AL, Legge M. Amino acid transport system L activity in developing mouse ovarian follicles. Human Reproduction 2011;26: 3102-3108.

Chavez C, Gogos A, Hill R, Van Sinderen M, Simpson E, Boon WC, van den Buuse M. Differential effect of amphetamine on c-fos expression in female aromatase knockout (ArKO) mice compared to wildtype controls. Psychoneuroendocrinology 2011;36: 761-768.

Chen Y, Wu H, Winnall WR, Loveland KL, Makanji Y, Phillips DJ, Smith JA, Hedger MP. Tumour necrosis factor-alpha stimulates human neutrophils to release preformed activin A. Immunology and Cell Biology 2011;89: 889-896.

Chow JD, Jones ME, Prelle K, Simpson ER, Boon WC. A selective estrogen receptor alpha agonist ameliorates hepatic steatosis in the male aromatase knockout mouse. The Journal of Endocrinology 2011;210: 323-334.

Chow JD, Price JT, Bills MM, Simpson ER, Boon WC. A doxycycline-inducible, tissue-specific aromatase-expressing transgenic mouse. Transgenic Research 2011 May 26 [Epub ahead of print]

Ciayadi R, Potdar M, Walton KL, Harrison CA, Kelso GF, Harris SJ, Hearn MT. 2-Phenyl and 2-heterocyclic-4-(3-(pyridin-2-yl)-1H-pyrazol-4-yl)pyridines as inhibitors of TGF-beta1 and activin A signalling. Bioorganic & Medicinal Chemistry Letters 2011;21: 5642-5645.

Cossigny DA, Findlay JK, Drummond A. The effects of FSH and Activin A on follicle development in vitro. Reproduction 2011 Nov 21 [Epub ahead of print]

Dimitriadis E, Menkhorst E. New generation contraceptives: interleukin 11 family cytokines as non-steroidal contraceptive targets. Journal of Reproductive Immunology 2011;88: 233-239.

Drummond AE, Fuller PJ. Activin and inhibin, estrogens and NFkappaB, play roles in ovarian tumourigenesis is there crosstalk? Molecular and Cellular Endocrinology 2011 Aug 4 [Epub ahead of print]

Evans J, Kaitu’u-Lino T, Salamonsen LA. Extracellular matrix dynamics in scar-free endometrial repair: perspectives from mouse in vivo and human in vitro studies. Biology of Reproduction 2011;85: 511-523.

Fuller P, Yao Y, Yang J, Young M. Mechanisms of ligand specificity of the mineralocorticoid receptor. The Journal of Endocrinology 2011 Dec 14 [Epub ahead of print]

Fuller PJ, Yao YZ, Komesaroff PA, Smith BJ, Zennaro MC. Pseudohypoaldosteronism type 1: the index case revisited. Clinical Endocrinology 2011;74: 408-410.

Funder J. Envoi. Reviews in Endocrine and Metabolic Disorders 2011;12: 53-54.

Funder J. Foreword. Reviews in Endocrine and Metabolic Disorders 2011;12: 1.

Funder J. Diagnosis and Treatment of Primary Aldosteronism Foreword. Reviews in Endocrine & Metabolic Disorders 2011;1:1.

Funder J. Mineralocorticoid receptor antagonists for heart failure. Expert Opinion on Pharmacotherapy 2011;12: 2767-2769.

Funder JW. Medicine. The genetics of primary aldosteronism. Science 2011;331: 685-686.

Funder JW. GPR30, mineralocorticoid receptors, and the rapid vascular effects of aldosterone. Hypertension 2011;57: 370-372.

Funder JW. Eplerenone, amlodipine and experimental hypertension: one plus one equals three. Hypertension Research 2011;34: 795-796.

Funder JW. Genetic modifications of corticosteroid receptors in hypertension. Advances in Experimental Medicine and Biology 2011;707: 111-113.

Funder JW. Aldosterone and mineralocorticoid receptors: A personal reflection. Molecular and Cellular Endocrinology 2011 Dec 14 [Epub ahead of print]

Garad R, Burger H, Davison S. Clinical Update: Exploring the Hormone Replacement Therapy debate. Australian Nursing Journal 2011;19: 30-33.

Hannan NJ, Evans J, Salamonsen LA. Alternate roles for immune regulators: establishing endometrial receptivity for implantation. Expert Review of Clinical Immunology 2011;7: 789-802.

Hannan NJ, Paiva P, Meehan KL, Rombauts LJ, Gardner DK, Salamonsen LA. Analysis of fertility-related soluble mediators in human uterine fluid identifies VEGF as a key regulator of embryo implantation. Endocrinology 2011;152: 4948-4956.

Harrison CA, Al-Musawi SL, Walton KL. Prodomains regulate the synthesis, extracellular localisation and activity of TGF-beta superfamily ligands. Growth Factors 2011;29: 174-186.

Heng S, Cervero A, Simon C, Stephens AN, Li Y, Zhang J, Paule S, Rainczuk A, Singh H, Quinonero A, Tapia A, Velasquez L, Salamonsen L, Rombauts LJ, Nie G. Proprotein convertase 5/6 is critical for embryo implantation in women: regulating receptivity by cleaving EBP50, modulating ezrin binding, and membrane-cytoskeletal interactions. Endocrinology 2011;152: 5041-5052.

Heng S, Hannan NJ, Rombauts LJ, Salamonsen LA, Nie G. PC6 levels in uterine lavage are closely associated with uterine receptivity and significantly lower in a subgroup of women with unexplained infertility. Human Reproduction 2011;26: 840-846.

Herlihy AS, Gillam L. Thinking outside the square: considering gender in Klinefelter syndrome and 47, XXY. International Journal of Andrology 2011;34: E348-E349.

Herlihy AS, Gillam L, Halliday JL, McLachlan RI. Postnatal screening for Klinefelter syndrome: is there a rationale? Acta Paediatrica 2011;100: 923-933.

Herlihy AS, Halliday JL, Cock ML, McLachlan RI. The prevalence and diagnosis rates of Klinefelter syndrome: an Australian comparison. Medical Journal of Australia 2011;194: 24-28.

Herlihy AS, McLachlan RI, Gillam L, Cock ML, Collins V, Halliday JL. The psychosocial impact of Klinefelter syndrome and factors influencing quality of life. Genetics in Medicine 2011;13: 632-642.

Jamsai D, Sarraj MA, Merriner DJ, Drummond AE, Jones KT, McLachlan RI, O’Bryan MK. GGN1 in the testis and ovary and its variance within the Australian fertile and infertile male population. International Journal of Andrology 2011;34: 624-632.

Kashimada K, Svingen T, Feng CW, Pelosi E, Bagheri-Fam S, Harley VR, Schlessinger D, Bowles J, Koopman P. Antagonistic regulation of Cyp26b1 by transcription factors SOX9/SF1 and FOXL2 during gonadal development in mice. FASEB Journal 2011;25: 3561-3569.

Kassahn KS, Ragan MA, Funder JW. Mineralocorticoid receptors: evolutionary and pathophysiological considerations. Endocrinology 2011;152: 1883-1890.

Keenan DM, Clarke IJ, Veldhuis JD. Noninvasive analytical estimation of endogenous GnRH drive: analysis using graded competitive GnRH-receptor antagonism and a calibrating pulse of exogenous GnRH. Endocrinology 2011;152: 4882-4893.

Knower KC, Kelly S, Ludbrook LM, Bagheri-Fam S, Sim H, Bernard P, Sekido R, Lovell-Badge R, Harley VR. Failure of SOX9 regulation in 46XY disorders of sex development with SRY, SOX9 and SF1 mutations. PLoS ONE 2011;6: e17751.

Kulkarni J, de Castella A, Headey B, Marston N, Sinclair K, Lee S, Gurvich C, Fitzgerald PB, Burger H. Estrogens and men with schizophrenia: Is there a case for adjunctive therapy? Schizophrenia Research 2011;125: 278-283.

Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK, Ahmed N. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile. Journal of Cellular Biochemistry 2011;112: 2850-2864.

Li Y, Puryer M, Lin E, Hale K, Salamonsen LA, Manuelpillai U, Tong S, Chan W, Wallace EM, Nie G. Placental HtrA3 is regulated by oxygen tension and serum levels are altered during early pregnancy in women destined to develop preeclampsia. Journal of Clinical Endocrinology and Metabolism 2011;96: 403-411.

Liew SH, Sarraj MA, Drummond AE, Findlay JK. Estrogen-dependent gene expression in the mouse ovary. PLoS ONE 2011;6: e14672.

Ludbrook L, Harley VR. Genetic mechanisms underlying 46,XY DSD with gonadal dysgenesis. Advances in Experimental Medicine and Biology 2011;707: 87-88.

Makanji Y, Harrison CA, Robertson DM. Feedback regulation by inhibins A and B of the pituitary secretion of follicle-stimulating hormone. Vitamins and Hormones 2011;85: 299-321.

Makanji Y, Walton KL, Chan KL, Gregorevic P, Robertson DM, Harrison CA. Generation of a specific activin antagonist by modification of the activin A propeptide. Endocrinology 2011;152: 3758-3768.

McLachlan RI, Ishikawa T, Osianlis T, Robinson P, Merriner DJ, Healy D, de Kretser D, O’Bryan MK. Normal live birth after testicular sperm extraction and intracytoplasmic sperm injection in variant primary ciliary dyskinesia with completely immotile sperm and structurally abnormal sperm tails. Fertility and Sterility 2011 Dec 1 [Epub ahead of print]

Mellor KM, Bell JR, Young MJ, Ritchie RH, Delbridge LMD. Myocardial autophagy activation and suppressed survival signaling is associated with insulin resistance in fructose-fed mice. Journal of Molecular and Cellular Cardiology 2011;50: 1035-1043.

Mendis SH, Meachem SJ, Sarraj MA, Loveland KL. Activin A balances Sertoli and germ cell proliferation in the fetal mouse testis. Biology of Reproduction 2011;84: 379-391.

Menkhorst E, Zhang JG, Sims NA, Morgan PO, Soo P, Poulton IJ, Metcalf D, Alexandrou E, Gresle M, Salamonsen LA, Butzkueven H, Nicola NA, Dimitriadis E. Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice. PLoS ONE 2011;6: e19665.

Milat F, Wong P, Fuller P, Johnstone L, Kerr P, Doery J, Strauss B, Bowden D. A case of hypophosphataemic osteomalacia secondary to deferasirox therapy. Journal of Bone and Mineral Research 2011 Sep 28 [Epub ahead of print]

Nicholls PK, Harrison CA, Walton KL, McLachlan RI, O’Donnell L, Stanton PG. Hormonal regulation of sertoli cell micro-RNAs at spermiation. Endocrinology 2011;152: 1670-1683.

Nicholls PK, Sun Z, Heng S, Li Y, Wang J, Nie G. Embryo implantation is closely associated with dynamic expression of proprotein convertase 5/6 in the rabbit uterus. Reproductive Biology and Endocrinology 2011;9: 43.

Nie G, Stephens AN. A proteomic protocol to identify physiological substrates of pro-protein convertases. Methods in Molecular Biology 2011;768: 325-341.

O’Donnell L, Nicholls PK, O’Bryan MK, McLachlan RI, Stanton PG. Spermiation: The process of sperm release. Spermatogenesis 2011;1: 14-35.

Paiva P, Hannan NJ, Hincks C, Meehan KL, Pruysers E, Dimitriadis E, Salamonsen LA. Human chorionic gonadotrophin regulates FGF2 and other cytokines produced by human endometrial epithelial cells, providing a mechanism for enhancing endometrial receptivity. Human Reproduction 2011;26: 1153-1162.

Paule S, Li Y, Nie G. Cytoskeletal remodelling proteins identified in fetal-maternal interface in pregnant women and rhesus monkeys. Journal of Molecular Histology 2011;42: 161-166.

Paule S, Meehan K, Rainczuk A, Stephens AN, Nie G. Combination of hydrogel nanoparticles and proteomics to reveal secreted proteins associated with decidualization of human uterine stromal cells. Proteome Science 2011;9: 50.

Pellatt L, Rice S, Dilaver N, Heshri A, Galea R, Brincat M, Brown K, Simpson ER, Mason HD. Anti-Mullerian hormone reduces follicle sensitivity to follicle-stimulating hormone in human granulosa cells. Fertility and Sterility 2011;96: 1246-1251.

Pippal JB, Cheung CM, Yao YZ, Brennan FE, Fuller PJ. Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor. Molecular and Cellular Endocrinology 2011;332: 58-66.

Quach JM, Walker EC, Allan E, Solano M, Yokoyama A, Kato S, Sims NA, Gillespie MT, Martin TJ. Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment. The Journal of Biological Chemistry 2011;286: 4186-4198.

Rickard AJ, Fuller PJ. Mineralocorticoid and epidermal growth factor receptors: partners in vivo. Hypertension 2011;57: 144-145.

Robertson DM. Hemochromatosis and ovarian cancer. Women’s Health (Lond Engl) 2011;7: 525-527.

Robertson DM. Inhibins and activins in blood: Predictors of female reproductive health? Molecular and Cellular Endocrinology 2011 June 1 [Epub ahead of print]

Robertson DM, Hale GE, Fraser IS, Hughes CL, Burger HG. Changes in serum antimullerian hormone levels across the ovulatory menstrual cycle in late reproductive age. Menopause 2011;18: 521-524.

Ryan J, Ludbrook L, Wilhelm D, Sinclair A, Koopman P, Bernard P, Harley VR. Analysis of gene function in cultured embryonic mouse gonads using nucleofection. Sexual Development 2011;5: 7-15.

Saleh H, Eeles D, Hodge JM, Nicholson GC, Gu R, Pompolo S, Gillespie MT, Quinn JMW. Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro. Endocrinology 2011;152: 1911-1922.

Samarajeewa NU, Ham S, Yang F, Simpson ER, Brown KA. Promoter-specific effects of metformin on aromatase transcript expression. Steroids 2011;76: 768-771.

Sarraj M, Drummond A. Fetal ovarian development, consequences for health and disease. Reproduction 2011 Nov 21 [Epub ahead of print]

Schimmer BP, Funder JW. ACTH, adrenal steroids and pharmacology of the adrenal cortex. In: Brunton LL, editor. Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 12th ed: McGraw Hill Medical; 2011, p. 1209-1235.

Schofield DJ, Meachem S, West C, Kavallaris M, Callander EJ. A crisis in the making? Education, ageing populations and the future of the medical research workforce. Medical Education 2011;45: 200-207.

Shuya LL, Menkhorst EM, Yap J, Li P, Lane N, Dimitriadis E. Leukemia inhibitory factor enhances endometrial stromal cell decidualization in humans and mice. PLoS ONE 2011;6: e25288.

Sim H, Argentaro A, Czech DP, Bagheri-Fam S, Sinclair AH, Koopman P, Boizet-Bonhoure B, Poulat F, Harley VR. Inhibition of SRY-calmodulin complex formation induces ectopic expression of ovarian cell markers in developing XY gonads. Endocrinology 2011;152: 2883-2893.

Singh H, Endo Y, Nie G. Decidual HtrA3 negatively regulates trophoblast invasion during human placentation. Human Reproduction 2011;26: 748-757.

Singh PP, Joshi S, Russell PJ, Nair S, Khatri A. Purine Nucleoside Phosphorylase mediated molecular chemotherapy and conventional chemotherapy: a tangible union against chemoresistant cancer. BMC Cancer 2011;11: 368.

Singh PP, Joshi S, Russell PJ, Verma ND, Wang XC, Khatri A. Molecular chemotherapy and chemotherapy: A new front against late-stage hormone-refractory prostate cancer. Clinical Cancer Research 2011;17: 4006-4018.

Sonderegger S, Yap J, Menkhorst E, Weston G, Stanton PG, Dimitriadis E. Interleukin (IL)11 mediates protein secretion and modification in human extravillous trophoblasts. Human Reproduction 2011;26: 2841-2849.

Sutton E, Hughes J, White S, Sekido R, Tan J, Arboleda V, Rogers N, Knower K, Rowley L, Eyre H, Rizzoti K, McAninch D, Goncalves J, Slee J, Turbitt E, Bruno D, Bengtsson H, Harley V, Vilain E, Sinclair A, Lovell-Badge R, Thomas P. Identification of SOX3 as an XX male sex reversal gene in mice and humans. Journal of Clinical Investigation 2011;121: 328-341.

Tang P, Argentaro A, Pask AJ, O’Donnell L, Marshall-Graves J, Familari M, Harley VR. Localization of the chromatin remodelling protein, ATRX in the adult testis. The Journal of Reproduction and Development 2011;57: 317-321.

Tang P, Frankenberg S, Argentaro A, Graves JM, Familari M. Comparative analysis of the ATRX promoter and 5’ regulatory region reveals conserved regulatory elements which are linked to roles in neurodevelopment, alpha-globin regulation and testicular function. BMC Research Notes 2011;4: 200.

Tonge B, Kenny R, Stanic D, Simpson E, Rinehart N, Boon WC. Testing the ‘Extreme male brain theory’. Journal of Intellectual Disability Research 2011;55: 954-954.

Walker KA, Sims-Lucas S, Caruana G, Cullen-McEwen L, Li J, Sarraj MA, Bertram JF, Stenvers KL. Betaglycan is required for the establishment of nephron endowment in the mouse. PLoS ONE 2011;6: e18723.

Walton KL, Makanji Y, Harrison CA. New insights into the mechanisms of activin action and inhibition. Molecular and Cellular Endocrinology 2011 July 19 [Epub ahead of print]

Walton KL, Makanji Y, Robertson DM, Harrison CA. The synthesis and secretion of inhibins. Vitamins and Hormones 2011;85: 149-184.

Wang C, Ilani N, Arver S, McLachlan RI, Soulis T, Watkinson A. Efficacy and safety of the 2% formulation of testosterone topical solution applied to the axillae in androgen-deficient men. Clinical Endocrinology 2011;75: 836-843.

Weisberg E, Croxatto HB, Findlay JK, Burger HG, Fraser IS. A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon(R). Contraception 2011;84: 600-608.

Whiley PA, Miyamoto Y, McLachlan RI, Jans DA, Loveland KL. Changing subcellular localization of nuclear transport factors during human spermatogenesis. International Journal of Andrology 2011 Aug 4. [Epub ahead of print]

White S, Ohnesorg T, Notini A, Roeszler K, Hewitt J, Daggag H, Smith C, Turbitt E, Gustin S, van den Bergen J, Miles D, Western P, Arboleda V, Schumacher V, Gordon L, Bell K, Bengtsson H, Speed T, Hutson J, Warne G, Harley V, Koopman P, Vilain E, Sinclair A. Copy number variation in patients with disorders of sex development due to 46,XY gonadal dysgenesis. PLoS ONE 2011;6: e17793.

Yang J, Chang CY, Safi R, Morgan J, McDonnell DP, Fuller PJ, Clyne CD, Young MJ. Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display. Molecular Endocrinology 2011;25: 32-43.

Yang J, Fuller PJ. Interactions of the mineralocorticoid receptor - within and without. Molecular and Cellular Endocrinology 2011 July 26 [Epub ahead of print]

Yao YW, Shi Y, Jia ZF, Jiang YH, Gu Z, Wang J, Aljofan M, Sun ZG. PTOV1 is associated with UCH-L1 and in response to estrogen stimuli during the mouse oocyte development. Histochemistry and Cell Biology 2011;136: 205-215.

Yap J, Foo CF, Lee MY, Stanton PG, Dimitriadis E. Proteomic analysis identifies interleukin 11 regulated plasma membrane proteins in human endometrial epithelial cells in vitro. Reproductive Biology and Endocrinology 2011;9: 73.

Young MJ, Rickard AJ. Mechanisms of mineralocorticoid salt-induced hypertension and cardiac fibrosis. Molecular and Cellular Endocrinology 2011 Sept 21 [Epub ahead of print]